Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.

Butt ZA, Mak S, Gesink D, Gilbert M, Wong J, Yu A, Wong S, Alvarez M, Chong M, Buxton J, Tyndall M, Krajden M, Janjua NZ.

J Viral Hepat. 2019 Mar;26(3):373-383. doi: 10.1111/jvh.13043. Epub 2018 Dec 11.

PMID:
30447122
2.

Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals.

Butt ZA, Shrestha N, Gesink D, Murti M, Buxton JA, Gilbert M, Balshaw RF, Wong S, Kuo M, Wong J, Yu A, Alvarez M, Samji H, Roth D, Consolacion T, Hull MW, Ogilvie G, Tyndall MW, Krajden M, Janjua NZ.

Clin Epidemiol. 2018 Aug 31;10:1127-1145. doi: 10.2147/CLEP.S173449. eCollection 2018.

3.

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.

Rossi C, Butt ZA, Wong S, Buxton JA, Islam N, Yu A, Darvishian M, Gilbert M, Wong J, Chapinal N, Binka M, Alvarez M, Tyndall MW, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team.

J Hepatol. 2018 Nov;69(5):1007-1014. doi: 10.1016/j.jhep.2018.07.025. Epub 2018 Aug 22.

PMID:
30142429
4.

Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.

Darvishian M, Janjua NZ, Chong M, Cook D, Samji H, Butt ZA, Yu A, Alvarez M, Yoshida E, Ramji A, Wong J, Woods R, Tyndall M, Krajden M.

J Viral Hepat. 2018 Dec;25(12):1481-1492. doi: 10.1111/jvh.12977. Epub 2018 Aug 28.

PMID:
30047609
5.

Pomona Large Vessel Occlusion Screening Tool for Prehospital and Emergency Room Settings.

Panichpisal K, Nugent K, Singh M, Rovin R, Babygirija R, Moradiya Y, Tse-Chang K, Jones KA, Woolfolk KJ, Keasler D, Desai B, Sakdanaraseth P, Sakdanaraseth P, Moalem A, Janjua N.

Interv Neurol. 2018 Apr;7(3-4):196-203. doi: 10.1159/000486515. Epub 2018 Feb 13.

6.

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.

Binka M, Butt ZA, Wong S, Chong M, Buxton JA, Chapinal N, Yu A, Alvarez M, Darvishian M, Wong J, McGowan G, Torban M, Gilbert M, Tyndall M, Krajden M, Janjua NZ.

World J Gastroenterol. 2018 Mar 21;24(11):1216-1227. doi: 10.3748/wjg.v24.i11.1216.

7.

Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.

Janjua NZ, Islam N, Kuo M, Yu A, Wong S, Butt ZA, Gilbert M, Buxton J, Chapinal N, Samji H, Chong M, Alvarez M, Wong J, Tyndall MW, Krajden M; BC Hepatitis Testers Cohort Team.

Int J Drug Policy. 2018 May;55:31-39. doi: 10.1016/j.drugpo.2018.02.001. Epub 2018 Feb 23.

PMID:
29482150
8.

Association between environmental tobacco smoke and dental caries amongst 5-14 years old children in Karachi, Pakistan.

Nayani AA, Iqbal R, Azam SI, Khan FR, Khan AH, Janjua N, Hussain A.

J Pak Med Assoc. 2018 Feb;68(2):203-209.

9.

Reducing patient and provider knowledge gaps: An evaluation of a community informed hepatitis C online course.

Buller-Taylor T, McGuinness L, Yan M, Janjua NZ.

Patient Educ Couns. 2018 Jun;101(6):1095-1102. doi: 10.1016/j.pec.2018.01.008. Epub 2018 Jan 10.

PMID:
29370951
10.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.

Alavi M, Janjua NZ, Chong M, Grebely J, Aspinall EJ, Innes H, Valerio H, Hajarizadeh B, Hayes PC, Krajden M, Amin J, Law MG, George J, Goldberg DJ, Hutchinson SJ, Dore GJ.

J Viral Hepat. 2018 May;25(5):473-481. doi: 10.1111/jvh.12837. Epub 2018 Feb 6.

PMID:
29194861
11.

Derivation and Validation of the Emergency Medical Stroke Assessment and Comparison of Large Vessel Occlusion Scales.

Gropen TI, Boehme A, Martin-Schild S, Albright K, Samai A, Pishanidar S, Janjua N, Brandler ES, Levine SR.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):806-815. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.018. Epub 2017 Nov 22.

PMID:
29174289
12.

Aggressive differentiated thyroid cancer.

Janjua N, Wreesmann VB.

Eur J Surg Oncol. 2018 Mar;44(3):367-377. doi: 10.1016/j.ejso.2017.09.019. Epub 2017 Oct 6. Review.

PMID:
29169931
13.

Laser-induced synlabia, cryptomenorrhea, and urine retention: A case report and literature review.

Fadul-Elahi T, Janjua NB.

Urol Ann. 2017 Oct-Dec;9(4):380-383. doi: 10.4103/UA.UA_7_17.

14.

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.

Alavi M, Janjua NZ, Chong M, Grebely J, Aspinall EJ, Innes H, Valerio HM, Hajarizadeh B, Hayes PC, Krajden M, Amin J, Law MG, George J, Goldberg DJ, Hutchinson SJ, Dore GJ.

J Hepatol. 2018 Mar;68(3):393-401. doi: 10.1016/j.jhep.2017.10.019. Epub 2017 Oct 26.

PMID:
29107152
15.

Hepatitis C cross-genotype immunity and implications for vaccine development.

Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Wong J, Tyndall MW, Janjua NZ; The BC-HTC Team.

Sci Rep. 2017 Sep 26;7(1):12326. doi: 10.1038/s41598-017-10190-8.

16.

A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.

Butt ZA, Shrestha N, Wong S, Kuo M, Gesink D, Gilbert M, Wong J, Yu A, Alvarez M, Samji H, Buxton JA, Johnston JC, Cook VJ, Roth D, Consolacion T, Murti M, Hottes TS, Ogilvie G, Balshaw R, Tyndall MW, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort.

PLoS One. 2017 Aug 22;12(8):e0183609. doi: 10.1371/journal.pone.0183609. eCollection 2017.

17.

Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.

Samji H, Yu A, Kuo M, Alavi M, Woods R, Alvarez M, Dore GJ, Tyndall M, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team.

J Hepatol. 2017 Nov;67(5):909-917. doi: 10.1016/j.jhep.2017.06.025. Epub 2017 Jul 4.

PMID:
28684103
18.

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.

Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Buxton JA, Wong J, Tyndall MW, Janjua NZ; British Columbia Hepatitis Testers Cohort (BC-HTC) team.

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):200-210. doi: 10.1016/S2468-1253(16)30182-0. Epub 2016 Dec 23. Erratum in: Lancet Gastroenterol Hepatol. 2017 Mar;2(3):e2.

PMID:
28404135
19.

Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.

Janjua NZ, Islam N, Wong J, Yoshida EM, Ramji A, Samji H, Butt ZA, Chong M, Cook D, Alvarez M, Darvishian M, Tyndall M, Krajden M.

J Viral Hepat. 2017 Aug;24(8):624-630. doi: 10.1111/jvh.12684. Epub 2017 Feb 20.

PMID:
28130810
20.

Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort.

Islam N, Krajden M, Gilbert M, Gustafson P, Yu A, Kuo M, Chong M, Alvarez M, Wong J, Tyndall MW, Janjua NZ.

J Viral Hepat. 2017 May;24(5):421-429. doi: 10.1111/jvh.12650. Epub 2016 Nov 25.

PMID:
27885757
21.

Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.

Janjua NZ, Chong M, Kuo M, Woods R, Wong J, Yoshida EM, Sherman M, Butt ZA, Samji H, Cook D, Yu A, Alvarez M, Tyndall M, Krajden M.

J Hepatol. 2017 Mar;66(3):504-513. doi: 10.1016/j.jhep.2016.10.028. Epub 2016 Nov 4.

PMID:
27818234
22.

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).

Janjua NZ, Kuo M, Yu A, Alvarez M, Wong S, Cook D, Wong J, Grebely J, Butt ZA, Samji H, Ramji A, Tyndall M, Krajden M.

EBioMedicine. 2016 Oct;12:189-195. doi: 10.1016/j.ebiom.2016.08.035. Epub 2016 Aug 25.

23.

Radical scavenging propensity of Cu2+, Fe3+ complexes of flavonoids and in-vivo radical scavenging by Fe3+-primuletin.

Jabeen E, Janjua NK, Ahmed S, Murtaza I, Ali T, Hameed S.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jan 15;171:432-438. doi: 10.1016/j.saa.2016.08.035. Epub 2016 Aug 22.

PMID:
27572737
24.

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.

Janjua NZ, Yu A, Kuo M, Alvarez M, Cook D, Wong J, Tyndall MW, Krajden M.

BMC Infect Dis. 2016 Jul 19;16:334. doi: 10.1186/s12879-016-1683-z.

25.

Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress.

Janjua NZ, Butt ZA, Mahmood B, Altaf A.

World J Gastroenterol. 2016 Jul 7;22(25):5837-52. doi: 10.3748/wjg.v22.i25.5837. Review.

26.

Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing.

Montoya V, Olmstead A, Tang P, Cook D, Janjua N, Grebely J, Jacka B, Poon AF, Krajden M.

Infect Genet Evol. 2016 Sep;43:329-37. doi: 10.1016/j.meegid.2016.06.015. Epub 2016 Jun 6.

PMID:
27282472
27.

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.

Janjua NZ, Kuo M, Chong M, Yu A, Alvarez M, Cook D, Armour R, Aiken C, Li K, Mussavi Rizi SA, Woods R, Godfrey D, Wong J, Gilbert M, Tyndall MW, Krajden M.

PLoS One. 2016 Mar 8;11(3):e0150176. doi: 10.1371/journal.pone.0150176. eCollection 2016.

28.

Multidisciplinary care of a paediatric patient with Gradenigo's syndrome.

Janjua N, Bajalan M, Potter S, Whitney A, Sipaul F.

BMJ Case Rep. 2016 Feb 25;2016. pii: bcr2015214337. doi: 10.1136/bcr-2015-214337.

29.

Barriers and Facilitators of Compliance with Universal Precautions at First Level Health Facilities in Northern Rural Pakistan.

Yousafzai MT, Janjua NZ, Siddiqui AR, Rozi S.

Int J Health Sci (Qassim). 2015 Oct;9(4):388-99.

30.

Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011.

Kuo M, Janjua NZ, Burchell AN, Buxton JA, Krajden M, Gilbert M.

Am J Public Health. 2015 Aug;105(8):1604-10. doi: 10.2105/AJPH.2015.302591. Epub 2015 Jun 11.

31.

Association of household and community socioeconomic position and urbanicity with underweight and overweight among women in Pakistan.

Janjua NZ, Mahmood B, Bhatti JA, Khan MI.

PLoS One. 2015 Apr 2;10(4):e0122314. doi: 10.1371/journal.pone.0122314. eCollection 2015.

32.

Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada.

Ling DI, Janjua NZ, Wong S, Krajden M, Hoang L, Morshed M, Achen M, Murti M, Lester RT, Wong J, Ogilvie G, Gilbert M.

Sex Transm Dis. 2015 Mar;42(3):153-9. doi: 10.1097/OLQ.0000000000000250.

PMID:
25668648
33.

Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation.

Montoya V, Olmstead AD, Janjua NZ, Tang P, Grebely J, Cook D, Richard Harrigan P, Krajden M.

Hepatology. 2015 Jun;61(6):1842-50. doi: 10.1002/hep.27734. Epub 2015 Mar 18.

PMID:
25645961
34.

Transradial access in acute ischemic stroke intervention.

Haussen DC, Nogueira RG, DeSousa KG, Pafford RN, Janjua N, Ramdas KN, Peterson EC, Elhammady MS, Yavagal DR.

J Neurointerv Surg. 2016 Mar;8(3):247-50. doi: 10.1136/neurintsurg-2014-011519. Epub 2015 Jan 5.

PMID:
25561585
35.

Reporting the results of a controlled trial.

Janjua NZ, Bhatti JA, Rizwan F.

J Pak Med Assoc. 2014 Aug;64(8):970-3. No abstract available.

36.

Writing the introduction and methods of a controlled trial.

Bhatti JA, Janjua NZ, Akhtar U, Azad A.

J Pak Med Assoc. 2014 Jun;64(6):720-2. No abstract available.

37.

Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.

Aspinall EJ, Hutchinson SJ, Janjua NZ, Grebely J, Yu A, Alavi M, Amin J, Goldberg DJ, Innes H, Law M, Walter SR, Krajden M, Dore GJ.

J Hepatol. 2015 Feb;62(2):269-77. doi: 10.1016/j.jhep.2014.09.001. Epub 2014 Sep 6.

PMID:
25200903
38.

Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.

Skowronski DM, Chambers C, Sabaiduc S, Janjua NZ, Li G, Petric M, Krajden M, Purych D, Li Y, De Serres G.

J Infect Dis. 2015 Jan 1;211(1):109-14. doi: 10.1093/infdis/jiu366. Epub 2014 Jun 27.

PMID:
24973459
39.

Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology.

Qureshi AI, Abd-Allah F, Aleu A, Connors JJ, Hanel RA, Hassan AE, Hussein HM, Janjua NA, Khatri R, Kirmani JF, Mazighi M, Mattle HP, Miley JT, Nguyen TN, Rodriguez GJ, Shah QA, Siddiqui AH, Suarez JI, Suri MF, Tolun R.

J Vasc Interv Neurol. 2014 May;7(1):56-75.

40.

Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan?

Janjua NZ, Mahmood B, Imran Khan M.

J Infect Public Health. 2014 Jul-Aug;7(4):345-55. doi: 10.1016/j.jiph.2014.04.001. Epub 2014 May 23.

41.

Aneurysmal bone cyst of the ethmoid bone.

Janjua N, Cresswell M, Sharma R, Maheshwar A.

BMJ Case Rep. 2014 Apr 4;2014. pii: bcr2013202319. doi: 10.1136/bcr-2013-202319.

42.

β-Cyclodextrin assisted solubilization of Cu and Cr complexes of flavonoids in aqueous medium: a DNA-interaction study.

Jabeen E, Janjua NK, Hameed S.

Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jul 15;128:191-6. doi: 10.1016/j.saa.2014.02.132. Epub 2014 Mar 12.

PMID:
24667424
43.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

44.

Oral administration of eicosapentaenoic acid or docosahexaenoic acid modifies cardiac function and ameliorates congestive heart failure in male rats.

Yamanushi TT, Kabuto H, Hirakawa E, Janjua N, Takayama F, Mankura M.

J Nutr. 2014 Apr;144(4):467-74. doi: 10.3945/jn.113.175125. Epub 2014 Feb 12.

PMID:
24523492
45.

Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.

Skowronski DM, Hamelin ME, De Serres G, Janjua NZ, Li G, Sabaiduc S, Bouhy X, Couture C, Leung A, Kobasa D, Embury-Hyatt C, de Bruin E, Balshaw R, Lavigne S, Petric M, Koopmans M, Boivin G.

PLoS One. 2014 Jan 27;9(1):e86555. doi: 10.1371/journal.pone.0086555. eCollection 2014.

46.

Factors related to the sensitivity of emergency medical service impression of stroke.

Gropen TI, Gokaldas R, Poleshuck R, Spencer J, Janjua N, Szarek M, Brandler ES, Levine SR.

Prehosp Emerg Care. 2014 Jul-Sep;18(3):387-92. doi: 10.3109/10903127.2013.864359. Epub 2014 Jan 24.

PMID:
24460036
47.

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.

Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M.

J Infect Dis. 2014 Jul 1;210(1):126-37. Epub 2014 Jan 19.

PMID:
24446529
48.

Thrombectomy for delayed basilar stent occlusion with good outcome.

Janjua N, Farkas J.

J Vasc Interv Neurol. 2013 Dec;6(2):19-24.

49.

Systemization of advanced stroke care: the dollars and sense of comprehensive stroke centers.

Janjua N, Qureshi AI, Zaidat OO.

J Neurointerv Surg. 2014 Apr 1;6(3):162-5. doi: 10.1136/neurintsurg-2013-010938. Epub 2013 Sep 23. No abstract available.

PMID:
24062255
50.

Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy.

Zaidat OO, Lazzaro MA, Linfante I, Nguyen T, Janjua N.

Neurology. 2013 Jul 16;81(3):305-6. No abstract available.

PMID:
24024232

Supplemental Content

Loading ...
Support Center